OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ACLX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Arcellx (ACLX) Earnings Date & Reports

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ACLX is expected to report earnings to rise 7.45% to -100 cents per share on November 17

Q3'25

Est.

$-1.01

Q2'25

Beat

by $0.08

Q1'25

Missed

by $0.37

Q4'24

Missed

by $0.31

Q3'24

Missed

by $0.14

The last earnings report on August 07 showed earnings per share of -93 cents, beating the estimate of -101 cents. With 867.67K shares outstanding, the current market capitalization sits at 3.91B.

View a ticker or compare two or three

Compare

ACLX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ACLX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACLX showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

800 Bridge Parkway

Phone

+1 240 327-0603

Employees

130

Web

https://www.arcellx.com